CXCR4 and lymphoma: High levels of CXCR4 expression are significantly linked to distant metastasis, poor overall survival, and reduced disease-free survival in various cancer types, including breast, prostate, pancreatic, and lung cancers, as well as lymphoma and leukaemia, making it an independent prognostic factor in these diseases [84].